
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
Marie Brachet‐Botineau, Marion Polomski, Heidi A. Neubauer, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 240-240
Open Access | Times Cited: 66
Marie Brachet‐Botineau, Marion Polomski, Heidi A. Neubauer, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 240-240
Open Access | Times Cited: 66
Showing 1-25 of 66 citing articles:
Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Gholami, et al.
Pharmacological Research (2021) Vol. 167, pp. 105575-105575
Closed Access | Times Cited: 119
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Gholami, et al.
Pharmacological Research (2021) Vol. 167, pp. 105575-105575
Closed Access | Times Cited: 119
Insights into IL-6/JAK/STAT3 Signaling in the Tumor Microenvironment: Implications for Cancer Therapy
Win Lwin Thuya, Yang Cao, Paul Chi-Lui Ho, et al.
Cytokine & Growth Factor Reviews (2025)
Closed Access | Times Cited: 4
Win Lwin Thuya, Yang Cao, Paul Chi-Lui Ho, et al.
Cytokine & Growth Factor Reviews (2025)
Closed Access | Times Cited: 4
STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
Biology (2020) Vol. 9, Iss. 6, pp. 126-126
Open Access | Times Cited: 97
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
Biology (2020) Vol. 9, Iss. 6, pp. 126-126
Open Access | Times Cited: 97
STAT3 and STAT5 Activation in Solid Cancers
Sebastian Igelmann, Heidi A. Neubauer, Gerardo Ferbeyre
Cancers (2019) Vol. 11, Iss. 10, pp. 1428-1428
Open Access | Times Cited: 87
Sebastian Igelmann, Heidi A. Neubauer, Gerardo Ferbeyre
Cancers (2019) Vol. 11, Iss. 10, pp. 1428-1428
Open Access | Times Cited: 87
STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer
Nagendra Awasthi, Clifford Liongue, Alister C. Ward
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 87
Nagendra Awasthi, Clifford Liongue, Alister C. Ward
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 87
JAK-STAT in Early Hematopoiesis and Leukemia
Eirini S. Fasouli, Eleni Katsantoni
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 58
Eirini S. Fasouli, Eleni Katsantoni
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 58
Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3
Jeremy Hall, Zhuoran Zhang, S. Bhattacharya, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 1, pp. 102137-102137
Open Access | Times Cited: 11
Jeremy Hall, Zhuoran Zhang, S. Bhattacharya, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 1, pp. 102137-102137
Open Access | Times Cited: 11
Structural and functional consequences of the STAT5BN642H driver mutation
Elvin D. de Araujo, Fettah Erdogan, Heidi A. Neubauer, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 69
Elvin D. de Araujo, Fettah Erdogan, Heidi A. Neubauer, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 69
Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia
Govinda Poudel, Molly G. Tolland, Timothy P. Hughes, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3300-3300
Open Access | Times Cited: 38
Govinda Poudel, Molly G. Tolland, Timothy P. Hughes, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3300-3300
Open Access | Times Cited: 38
The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update
Maysaloun Merhi, Fareed Ahmad, Nassiba Taib, et al.
Seminars in Cancer Biology (2023) Vol. 89, pp. 1-17
Open Access | Times Cited: 22
Maysaloun Merhi, Fareed Ahmad, Nassiba Taib, et al.
Seminars in Cancer Biology (2023) Vol. 89, pp. 1-17
Open Access | Times Cited: 22
Targeting the STAT3 pathway with STAT3 degraders
Zhijie Wang, Xiaotong Liao, Haiqi He, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 811-823
Closed Access | Times Cited: 7
Zhijie Wang, Xiaotong Liao, Haiqi He, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 811-823
Closed Access | Times Cited: 7
STAT3 and p53: Dual Target for Cancer Therapy
Thu‐Huyen Pham, Hyo‐Min Park, Jinju Kim, et al.
Biomedicines (2020) Vol. 8, Iss. 12, pp. 637-637
Open Access | Times Cited: 41
Thu‐Huyen Pham, Hyo‐Min Park, Jinju Kim, et al.
Biomedicines (2020) Vol. 8, Iss. 12, pp. 637-637
Open Access | Times Cited: 41
Targeting the JAK2/STAT3 Pathway—Can We Compare It to the Two Faces of the God Janus?
Anna Jaśkiewicz, Tomasz Domoradzki, Beata Pająk
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8261-8261
Open Access | Times Cited: 34
Anna Jaśkiewicz, Tomasz Domoradzki, Beata Pająk
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8261-8261
Open Access | Times Cited: 34
JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies
Charlotte E. J. Downes, Barbara J. McClure, Daniel P. McDougal, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 20
Charlotte E. J. Downes, Barbara J. McClure, Daniel P. McDougal, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 20
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia
Tobias Suske, Helena Sorger, Gabriele Manhart, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 8
Open Access | Times Cited: 4
Tobias Suske, Helena Sorger, Gabriele Manhart, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 8
Open Access | Times Cited: 4
SAR317461 Inhibit JAK2/STAT3 Phosphorylation for Enhanced Anti-leukemia Activity
Xiaoyu Yang, Yan Wang, Lin Zhang, et al.
Indian Journal of Hematology and Blood Transfusion (2025)
Closed Access
Xiaoyu Yang, Yan Wang, Lin Zhang, et al.
Indian Journal of Hematology and Blood Transfusion (2025)
Closed Access
Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia
Annika Dechow, Sanna Timonen, Aleksandr Ianevski, et al.
Leukemia (2025)
Open Access
Annika Dechow, Sanna Timonen, Aleksandr Ianevski, et al.
Leukemia (2025)
Open Access
The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma
Susann Schönefeldt, Tamara Wais, Marco Herling, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6212-6212
Open Access | Times Cited: 24
Susann Schönefeldt, Tamara Wais, Marco Herling, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6212-6212
Open Access | Times Cited: 24
Repurposing of Acriflavine to Target Chronic Myeloid Leukemia Treatment
Rawan Nehme, Rawan Hallal, Maya El Dor, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 11, pp. 2218-2233
Open Access | Times Cited: 24
Rawan Nehme, Rawan Hallal, Maya El Dor, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 11, pp. 2218-2233
Open Access | Times Cited: 24
Activating mutations of STAT3: Impact on human growth
Mariana Gutiérrez
Molecular and Cellular Endocrinology (2020) Vol. 518, pp. 110979-110979
Closed Access | Times Cited: 22
Mariana Gutiérrez
Molecular and Cellular Endocrinology (2020) Vol. 518, pp. 110979-110979
Closed Access | Times Cited: 22
The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia
Bernhard Moser, Sophie Edtmayer, Agnieszka Witalisz‐Siepracka, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1051-1051
Open Access | Times Cited: 20
Bernhard Moser, Sophie Edtmayer, Agnieszka Witalisz‐Siepracka, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1051-1051
Open Access | Times Cited: 20
Inhibition of O-GlcNAcase Inhibits Hematopoietic and Leukemic Stem Cell Self-Renewal and Drives Dendritic Cell Differentiation via STAT3/5 Signaling
Sudjit Luanpitpong, Napachai Rodboon, Parinya Samart, et al.
Stem Cells (2022) Vol. 40, Iss. 12, pp. 1078-1093
Closed Access | Times Cited: 12
Sudjit Luanpitpong, Napachai Rodboon, Parinya Samart, et al.
Stem Cells (2022) Vol. 40, Iss. 12, pp. 1078-1093
Closed Access | Times Cited: 12
Development of Functional Foods: A Comparative Study on the Polyphenols and Anthocyanins Content in Chokeberry and Blueberry Pomace Extracts and Their Antitumor Properties
Loredana Stanca, Liviu Bîlteanu, Oana-Crina Bujor, et al.
Foods (2024) Vol. 13, Iss. 16, pp. 2552-2552
Open Access | Times Cited: 2
Loredana Stanca, Liviu Bîlteanu, Oana-Crina Bujor, et al.
Foods (2024) Vol. 13, Iss. 16, pp. 2552-2552
Open Access | Times Cited: 2
Exploring the protective mechanisms of total tannins from Geum japonicum var. chinense F.Bolle in mice with hematopoietic dysfunction via the JAK2/STAT3/5 signaling pathway
Wenbi Mu, Jingwen Ao, Yao Li, et al.
Journal of Ethnopharmacology (2022) Vol. 296, pp. 115507-115507
Closed Access | Times Cited: 10
Wenbi Mu, Jingwen Ao, Yao Li, et al.
Journal of Ethnopharmacology (2022) Vol. 296, pp. 115507-115507
Closed Access | Times Cited: 10
STAT3 governs the HIF-1α response in IL-15 primed human NK cells
Anna Coulibaly, Sonia Y. Velásquez, Nina Kassner, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Anna Coulibaly, Sonia Y. Velásquez, Nina Kassner, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 14